Spine News and Research

RSS

Massimo CEO wins Ernst & Young Entrepreneur Of The Year Award

Joe Kiani, founder, CEO and Chairman of the Board of Massimo Corporation, has been named the Ernst & Young National Entrepreneur Of The Year 2012 Life Sciences Award Winner.

19 Nov 2012

Two genetic factors strongly associated with non-syndromic sagittal craniosynostosis

An international team of geneticists, pediatricians, surgeons and epidemiologists from 23 institutions across three continents has identified two areas of the human genome associated with the most common form of non-syndromic craniosynostosis ― premature closure of the bony plates of the skull.

18 Nov 2012

First HSS medical symposium to take place in Rio de Janeiro from Nov. 28-29

The first medical symposium in Brazil presented by Hospitalys Ortopedia in Rio de Janeiro and New York City's Hospital for Special Surgery (HSS) will take place November 28 and 29 in Rio de Janeiro.

16 Nov 2012

Study finds several osteoporosis risk factors among post-menopausal women on HRT

A preliminary study of 127 post-menopausal women on hormone replacement therapy in Portugal suggests that there are several risk factors associated with osteoporosis and bone fracture these include age, low bone mineral density, a sedentary lifestyle, coffee consumption and ovariectomy. Details are reported later this month in the International Journal of Medical Engineering and Informatics.

14 Nov 2012

Thrombin sponge speeds cervical spine surgery discharge

Application of a thrombin-soaked sponge after posterior cervical spine surgery allows patients to leave hospital earlier than normally expected, suggests research.

9 Nov 2012

University of Leicester scientists identify unique forms of spinal nerve activity

Scientists from the University of Leicester have hit upon unique forms of spinal nerve activity that shape output of nerve cell networks controlling motor behaviours.

9 Nov 2012

Two-level cervical disc from LDR receives approvable letter from U.S. FDA

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced that it has received an Approvable Letter from the U.S. Food and Drug Administration (FDA) for its Mobi-C® Cervical Disc (Mobi-C). Mobi-C is a metal and polyethylene mobile bearing prosthesis specifically designed as a low-profile cervical intervertebral disc replacement for both one and two level applications.

7 Nov 2012

BioMimetic Therapeutics reports net loss of $4.6 million for third quarter 2012

BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.

6 Nov 2012

Nationwide standard on booster seat laws would save children’s lives

A new study by researchers in Boston Children's Hospital's Division of Emergency Medicine indicates that a nationwide standard on booster seat laws for children 4 feet 9 inches and shorter, or up to 8 years old, would save lives.

6 Nov 2012

New image guided instrumentation for DePuy Synthes Spine’s leading spine systems

DePuy Synthes Spine announced new image guided instrumentation for two of its leading spine systems and has entered into a new partnership agreement with Brainlab, enabling both companies to offer integrated surgical navigation and imaging solutions.

2 Nov 2012

FDA clears X-spine’s new Fortex and Certex system

X-spine, a global leader in the design and manufacture of devices for the treatment of spinal disease, today announced two new USFDA clearances for spinal systems: The Fortex CoCr Rod System and the Certex Cervico-thoracic Fixation System.

2 Nov 2012

Encouraging results from Gilead’s TAF Phase 2 trial on HIV-1 infection

Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.

1 Nov 2012

Encouraging results from stereotactic radiosurgery Phase I trial on kidney cancer

A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer.

1 Nov 2012

Autoantibody aids identification of hyperexcitability disorders

Researchers have found that testing for a glycine receptor autoantibody aids the identification of a broad spectrum of autoimmune brainstem/spinal cord hyperexcitability disorders.

29 Oct 2012

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.

29 Oct 2012

Senate investigation culminates in report criticizing Medtronic

The Senate Finance Committee alleges that the medical technology company played a hidden role in drafting studies about one of its products.

29 Oct 2012

Neuraxial anesthesia should be promoted for bilateral total knee replacements: HSS

Using regional anesthesia rather than general anesthesia reduces the need for blood transfusions in patients undergoing bilateral total knee replacement, according to a new study by researchers at Hospital for Special Surgery, in New York City.

29 Oct 2012

HSS announces opening of new Lerner Children's Pavilion

The new Pavilion within the #1 hospital for orthopedics in the country affirms HSS' longstanding commitment to championing children and caring for their musculoskeletal conditions.

26 Oct 2012

Senate panel says Medtronic ghostwrote positive medical journal studies on its spine treatment product

A Senate Finance Committee investigation also alleges that the company paid $210 million to 13 doctors who co-authored the studies.

26 Oct 2012

Simple educational intervention could improve treatment rates for osteoporosis

Older patients who visited local ERs for chest pain or breathing problems and had chest x-rays reveal unknown spinal fractures, were more apt to receive osteoporosis treatment afterward if a simple intervention was used, recently published medical research from the University of Alberta has found.

26 Oct 2012

Spine News and Research

Massimo CEO wins Ernst & Young Entrepreneur Of The Year Award

Two genetic factors strongly associated with non-syndromic sagittal craniosynostosis

First HSS medical symposium to take place in Rio de Janeiro from Nov. 28-29

Study finds several osteoporosis risk factors among post-menopausal women on HRT

Thrombin sponge speeds cervical spine surgery discharge

University of Leicester scientists identify unique forms of spinal nerve activity

Two-level cervical disc from LDR receives approvable letter from U.S. FDA

BioMimetic Therapeutics reports net loss of $4.6 million for third quarter 2012

Nationwide standard on booster seat laws would save children’s lives

New image guided instrumentation for DePuy Synthes Spine’s leading spine systems

FDA clears X-spine’s new Fortex and Certex system

Encouraging results from Gilead’s TAF Phase 2 trial on HIV-1 infection

Encouraging results from stereotactic radiosurgery Phase I trial on kidney cancer

Autoantibody aids identification of hyperexcitability disorders

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

Senate investigation culminates in report criticizing Medtronic

Neuraxial anesthesia should be promoted for bilateral total knee replacements: HSS

HSS announces opening of new Lerner Children's Pavilion

Senate panel says Medtronic ghostwrote positive medical journal studies on its spine treatment product

Simple educational intervention could improve treatment rates for osteoporosis

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News